Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

COX-2 and the kidneys.

Stichtenoth DO, Frölich JC.

Curr Pharm Des. 2000 Nov;6(17):1737-53. Review.

PMID:
11102561
2.

Renal effects of cyclooxygyenase-2-selective inhibitors.

Brater DC.

J Pain Symptom Manage. 2002 Apr;23(4 Suppl):S15-20; discussion S21-3. Review.

PMID:
11992745
3.

[Selective inhibitors of type 2 cyclooxygenase: less renal effects than the classical non-steroidal anti-inflammatory agents].

Chiolero A, Würzner G, Burnier M.

Nephrologie. 2000;21(8):425-30. Review. French.

PMID:
11213386
4.

Do non-steroidal anti-inflammatory drugs and COX-2 selective inhibitors have different renal effects?

Giovanni G, Giovanni P.

J Nephrol. 2002 Sep-Oct;15(5):480-8. Review.

PMID:
12455713
5.

Renal effects of non-steroidal anti-inflammatory drugs and selective cyclooxygenase-2 inhibitors.

Cheng HF, Harris RC.

Curr Pharm Des. 2005;11(14):1795-804. Review.

PMID:
15892676
6.
7.

New NSAIDs and gastroduodenal damage.

Folco GC.

Ital J Gastroenterol. 1996 Dec;28 Suppl 4:28-9. Review.

PMID:
9032579
8.

Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks.

Bertolini A, Ottani A, Sandrini M.

Curr Med Chem. 2002 May;9(10):1033-43. Review.

PMID:
12733982
9.
10.

[Coxibs: cyclooxygenase-2 inhibitors].

Turnheim K.

Wien Klin Wochenschr. 2001 Aug 16;113(15-16):558-65. Review. German.

PMID:
11571832
11.

Renal effects of COX-2-selective inhibitors.

Brater DC, Harris C, Redfern JS, Gertz BJ.

Am J Nephrol. 2001 Jan-Feb;21(1):1-15. Review.

PMID:
11275626
12.

Efficacy, safety and potential clinical roles of the COX-2-specific inhibitors.

van der Bijl P, van der Bijl P Jr.

Int J Immunopathol Pharmacol. 2003 May-Aug;16(2 Suppl):17-22. Review.

PMID:
14552700
13.

New directions in cyclooxygenase research and their implications for NSAID-gastropathy.

Flower RJ.

Ital J Gastroenterol. 1996 Dec;28 Suppl 4:23-7. Review.

PMID:
9032578
14.

Renal effects of nonselective NSAIDs and coxibs.

Weir MR.

Cleve Clin J Med. 2002;69 Suppl 1:SI53-8. Review.

PMID:
12086295
15.

Distinct isoforms (COX-1 and COX-2) of cyclooxygenase: possible physiological and therapeutic implications.

Pairet M, Engelhardt G.

Fundam Clin Pharmacol. 1996;10(1):1-17. Review.

PMID:
8900495
16.

Does cyclooxygenase-2 affect blood pressure?

Cheng HF, Harris RC.

Curr Hypertens Rep. 2003 Feb;5(1):87-92. Review.

PMID:
12530941
17.

Novel non-steroidal anti-inflammatory drugs: what we have learned from animal studies.

Coruzzi G, Menozzi A, Dobrilla G.

Curr Drug Targets Inflamm Allergy. 2004 Mar;3(1):43-61. Review.

PMID:
15032641
18.

The role of COX-2 in acute pain and the use of selective COX-2 inhibitors for acute pain relief.

Lee Y, Rodriguez C, Dionne RA.

Curr Pharm Des. 2005;11(14):1737-55. Review.

PMID:
15892672
19.

Cyclooxygenase-2 inhibitors: promise or peril?

Mengle-Gaw LJ, Schwartz BD.

Mediators Inflamm. 2002 Oct;11(5):275-86. Review.

20.

Cyclooxygenase-2 selective inhibitors and the kidney.

Breyer MD, Hao C, Qi Z.

Curr Opin Crit Care. 2001 Dec;7(6):393-400. Review.

PMID:
11805541

Supplemental Content

Support Center